FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT04444232` - Cancer Communication Within Hispanic Social Networks	N/A
Recruiting	`NCT06233253` - Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy	N/A
Recruiting	`NCT05799820` - QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC	Phase 2
Recruiting	`NCT04666727` - Role of Diet on the Microbiome of the Digestive System
Recruiting	`NCT04767984` - Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis	Phase 2
Recruiting	`NCT02376452` - Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients	Phase 2
Completed	`NCT02254486` - Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults	Phase 3
Completed	`NCT01486251` - Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer	N/A
Terminated	`NCT01233544` - Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases	Phase 3
Recruiting	`NCT02073500` - Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Completed	`NCT00704600` - Nelfinavir, a Phase I/Phase II Rectal Cancer Study	Phase 1/Phase 2
Completed	`NCT00485316` - Laparoscopic Assisted Versus Open Resection for Colorectal Carcinoma	Phase 3
Recruiting	`NCT04430738` - Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers	Phase 1/Phase 2
Terminated	`NCT02669914` - MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors	Phase 2
Completed	`NCT05022511` - Three Birds With One Stone	N/A
Completed	`NCT04607291` - Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening	Phase 1
Not yet recruiting	`NCT03969784` - Microparticles in Peritoneal Carcinomatosis of Colorectal Origin	N/A
Not yet recruiting	`NCT05630794` - Testing ONC201 to Prevent Colorectal Cancer	Phase 1
Terminated	`NCT05291988` - A Multilevel Approach for Improvement in Screening of Colorectal Cancer in Rural Communities, The Screen to Save Trial	N/A
Suspended	`NCT04108481` - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer	Phase 1/Phase 2

NCT number	NCT02935764
Study type	Interventional
Source	Fudan University
Contact
Status	Not yet recruiting
Phase	Phase 3
Start date	October 2016

FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms